These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. A health plan's integration of molecular diagnostics and the impact on treatment pathways for quality care. Wong W Manag Care; 2008 Jul; 17(7 Suppl 7):13-6; discussion 17-8. PubMed ID: 19093337 [TBL] [Abstract][Full Text] [Related]
5. A pathologist's perspective on emerging genomic tests for breast cancer. Symmans WF Semin Oncol; 2007 Apr; 34(2 Suppl 3):S4-9. PubMed ID: 17512433 [TBL] [Abstract][Full Text] [Related]
6. Molecular markers of breast axillary lymph node metastasis. Cavalli LR Expert Rev Mol Diagn; 2009 Jul; 9(5):441-54. PubMed ID: 19580429 [TBL] [Abstract][Full Text] [Related]
7. [Genomics and clinical research for breast cancer]. Bertucci F; Birnbaum D Med Sci (Paris); 2012 Mar; 28 Spec No 1():14-8. PubMed ID: 22494651 [TBL] [Abstract][Full Text] [Related]
8. Gene expression profiling in breast cancer. Nasser SM J Med Liban; 2009; 57(2):83-8. PubMed ID: 19623883 [TBL] [Abstract][Full Text] [Related]
9. Of what value genomics in colorectal cancer? Opportunities and challenges. Johnston PG J Clin Oncol; 2004 May; 22(9):1538-9. PubMed ID: 15051754 [No Abstract] [Full Text] [Related]
10. Translational research and the changing face of breast cancer. Dowsett M Breast Cancer Res Treat; 2004; 87 Suppl 1():S1-2. PubMed ID: 15597214 [TBL] [Abstract][Full Text] [Related]
11. [Breast cancer and molecular markers]. Ishioka C Gan To Kagaku Ryoho; 2008 Aug; 35(8):1261-8. PubMed ID: 18701834 [TBL] [Abstract][Full Text] [Related]
12. Breast cancer molecular subtypes in patients with locally advanced disease: impact on prognosis, patterns of recurrence, and response to therapy. Huber KE; Carey LA; Wazer DE Semin Radiat Oncol; 2009 Oct; 19(4):204-10. PubMed ID: 19732684 [TBL] [Abstract][Full Text] [Related]
13. Genomic analysis from tissue core biopsies: standard of care for the future? Sarkar S; Tuck DP; Harris LN Breast Cancer Res Treat; 2009 Dec; 118(3):645-6. PubMed ID: 19234784 [No Abstract] [Full Text] [Related]
14. Microarray-based gene expression profiling as a clinical tool for breast cancer management: are we there yet? Correa Geyer F; Reis-Filho JS Int J Surg Pathol; 2009 Aug; 17(4):285-302. PubMed ID: 19103611 [TBL] [Abstract][Full Text] [Related]
16. Multigene classifiers, prognostic factors, and predictors of breast cancer clinical outcome. Ross JS Adv Anat Pathol; 2009 Jul; 16(4):204-15. PubMed ID: 19546609 [TBL] [Abstract][Full Text] [Related]
17. Disseminated tumor cells: the method is the message. Park JW Breast Cancer Res Treat; 2011 Feb; 125(3):739-40. PubMed ID: 20700647 [No Abstract] [Full Text] [Related]
18. The influence of a gene expression profile on breast cancer decisions. Henry LR; Stojadinovic A; Swain SM; Prindiville S; Cordes R; Soballe PW J Surg Oncol; 2009 May; 99(6):319-23. PubMed ID: 19204954 [TBL] [Abstract][Full Text] [Related]
19. Is immunohistochemistry less sensitive than quantitative reverse transcriptase polymerase chain reaction for hormone receptor status determination in breast cancer? Arnould L; Coudert B; Fumoleau P J Clin Oncol; 2009 Jun; 27(16):2733; author reply 2734-5. PubMed ID: 19380432 [No Abstract] [Full Text] [Related]
20. [Molecular staging and prognosis in lung cancer]. Sánchez de Cos Escuín J Arch Bronconeumol; 2011 Nov; 47(11):539-40. PubMed ID: 21831500 [No Abstract] [Full Text] [Related] [Next] [New Search]